Journals / Turkish Journal of Veterinary and Animal Sciences / 2017 / Cilt: 41 - Sayı: 6

Extraskeletal chondroblastic osteosarcoma of the subcutaneous tissue in a Maltese dog

Pages
798–801
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the basis of histopathologic and immunohistochemical features, the tumor was diagnosed as anextraskeletal chondroblastic osteosarcoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 10-year-old spayed female Maltese dog presented to a local animal hospital with a subcutaneous mass (4 × 3 × 3 cm) inthe right shoulder region.
📊
Key Findings & Data:Round to polygonal neoplastic cells with large nuclei showedmoderate anisokaryosis and variable numbers of mitotic figures.
💡
Conclusion & Impact:On the basis of histopathologic and immunohistochemical features, the tumor was diagnosed as anextraskeletal chondroblastic osteosarcoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 10-year-old spayed female Maltese dog presented to a local animal hospital with a subcutaneous mass (4 × 3 × 3 cm) inthe right shoulder region. The mass was well circumscribed, with soft tissue opacity and variable levels of mineralization, but with nobony involvement in radiography. The mass was surgically removed. Upon histological examination, the mass consisted of malignantmesenchymal cells that had produced a chondroid matrix and osteoid. Round to polygonal neoplastic cells with large nuclei showedmoderate anisokaryosis and variable numbers of mitotic figures. The tumor cells were positive for vimentin and osteocalcin and negativefor pancytokeratin, S100, and C-kit. On the basis of histopathologic and immunohistochemical features, the tumor was diagnosed as anextraskeletal chondroblastic osteosarcoma.

🔖

Cite This Article

KIM, S., JU, J., CHOI, H., SEUNG, B., SUR, J., CHO, S. (2022). Extraskeletal chondroblastic osteosarcoma of the subcutaneous tissue in a Maltese dog. Turkish Journal of Veterinary and Animal Sciences, Cilt: 41 - Sayı: 6, 798–801. https://ajindex.com/articles/615039

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Langenbach A, Anderson MA, Dambach DM, Sorenmo KU, Shofer FD. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). J Am Anim Hosp Assoc 1998; 34: 113-120
  2. Patnaik AK. Canine extraskeletal osteosarcoma and chondrosarcoma: a clinicopathologic study of 14 cases. Vet Pathol 1990; 27: 46-55
  3. Kuntz CA, Dernell WS, Powers BE, Withrow S. Extraskeletal osteosarcomas in dogs: 14 cases. J Am Anim Hosp Assoc 1998; 34: 26-30
  4. Meuten DJ. Tumors in Domestic Animals. 5th ed. Ames, IA, USA: John Wiley & Sons Inc; 2017
  5. Brodey RS, Riser WH. Canine osteosarcoma: a clinicopathologic study of 194 cases. Clin Orthop Relat R 1969; 62: 54-64
  6. Liu SK, Dorfman HD, Hurvitz AI, Patnaik AK. Primary and secondary bone tumours in the dog. J Small Anim Pract 1977; 18: 313-326
  7. Tjalma RA. Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer I 1966; 36: 1137-1150
  8. Duffy D, Selmic LE, Kendall AR, Powers BE. Outcome following treatment of soft tissue and visceral extraskeletal osteosarcoma in 33 dogs: 2008-2013. Vet Comp Oncol 2017; 15: 46-54
  9. Miller MA, Aper RL, Fauber A, Blevins WE, Ramos-Vara JA. Extraskeletal osteosarcoma associated with retained surgical sponge in a dog. J Vet Diagn Invest 2006; 18: 224-228
  10. Selmic LE, Griffin LR, Rector MH, Lafferty M, Pool R, Ehrhart NP. Treatment of extraskeletal osteosarcoma at a previous injection site resulting in prolonged survival in 1 dog. Can Vet J 2016; 57: 950-954
  11. Vascellari M, Melchiotti E, Bozza MA, Mutinelli F. Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. Transbound Emerg Dis 2003; 50: 286-291.